病态肥胖增加全髋关节置换两阶段翻修术后再手术与失败风险
本研究回顾性分析了107例因假体周围感染接受首次两阶段翻修全髋关节置换术的患者,通过倾向性评分匹配形成非肥胖、肥胖和病态肥胖三组。结果显示病态肥胖患者再感染率和再手术率显著高于非肥胖和肥胖患者,提示病态肥胖是术后失败的重要危险因素,可用于术前咨询并支持推迟关节置换直至优化。
要点
- 病态肥胖患者再感染率33%显著高于非肥胖患者0%。
- 病态肥胖患者再手术率50%显著高于非肥胖13%和肥胖19%。
- 病态肥胖患者住院超过4天的比例61%显著高于非肥胖19%。
核心结论
- 病态肥胖患者因假体周围感染行两阶段翻修全髋关节置换术后再感染和再手术风险显著增加。
研究设计与样本
- 回顾性综述2013至2019年107例首次两阶段翻修全髋关节置换术的假体周围感染患者。
- 通过倾向性评分匹配形成非肥胖(<30 kg/m2)16例、肥胖(30-39.9 kg/m2)16例和病态肥胖(>40 kg/m2)18例三组。
- 平均随访时间非肥胖组36.3个月、肥胖组30.1个月、病态肥胖组40.0个月,至少12个月。
主要发现
- 病态肥胖组再感染率33%,非肥胖组0%(P = .020)。
- 病态肥胖组住院超过4天比例61%,非肥胖组19%(P = .012)。
- 病态肥胖组任何原因再手术率50%,肥胖组19%,非肥胖组13%(P = .020)。
- 三组在并发症、死亡或翻修手术方面无差异。
临床怎么用
- 病态肥胖患者再感染和再手术风险显著增高,可用于术前咨询。
- 支持对病态肥胖患者推迟关节置换直至优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While morbid obesity is associated with increased infection after total hip arthroplasty, little is known on the outcomes after 2-stage reimplantation for prosthetic joint infection (PJI) in this population. The purpose of this study is to evaluate the impact of morbid obesity (body mass index>40 kg/m2) on reinfection, postoperative complications, readmissions, and reoperations. METHODS: We conducted a retrospective review of 107 patients undergoing first time 2-stage reimplantation for PJI from 2013 to 2019. 18 patients (50% women) with body mass index>40 kg/m2 were identified. To minimize confounders, three propensity score matched cohorts were created, yielding 16 nonobese (<30 kg/m2), 16 obese (30-39.9 kg/m2), and 18 morbidly obese (>40 kg/m2) patients. Outcomes were compared using chi-square or Fisher's exact tests. All patients had minimum 12-month follow-up, with mean follow-up of 36.3, 30.1, and 40.0 months in the nonobese, obese, and morbidly obese cohorts, respectively. RESULTS: Compared with nonobese patients, morbidly obese patients had a higher rate of reinfection (0% vs 33%, P = .020 and higher likelihood of length of stay>4 days (19% vs 61%, P = .012). In addition, compared with nonobese and obese patients, morbidly obese patients had higher rate of return to the operating room for any reason (13% vs 19% vs 50%, respectively, P = .020). No differences between cohorts were found regarding complications, death, or revision surgery. CONCLUSION: Morbidly obese patients have significantly increased risk of reinfection and reoperation after 2-stage reimplantation for PJI when compared with obese and nonobese patients. These data can be used to counsel morbidly obese patients contemplating total hip arthroplasty and supports the notion of deferring arthroplasty in this population pending optimization.
引用
- Kerbel YE, Kirchner GJ, Meltzer-Bruhn AT, et al. Increasing Reoperations and Failures With Increasing BMI in Patients Undergoing 2-Stage Exchange for Infected Total Hip Arthroplasty. J Arthroplasty. 2021. PMID: 33840543. doi:10.1016/j.arth.2021.03.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。